August 16, 2022 – Merck & Co. is delving deeper into RNA drugmaking, announcing on Tuesday a lucrative deal with biotechnology startup Orna Therapeutics that it hopes could lead to multiple new drugs and vaccines.
August 16, 2022 – Merck & Co. is delving deeper into RNA drugmaking, announcing on Tuesday a lucrative deal with biotechnology startup Orna Therapeutics that it hopes could lead to multiple new drugs and vaccines.